Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

UARK 2005-33: Phase 3, open label, randomized comparative study of ticilimumab and either dacarbazine or temozolomide in patients with advanced melano


Collapse Overview 
Collapse sponsor award id
Pfizer A3671009


Collapse Biography 

Collapse Time 
Collapse start date
2006-08-08

Collapse end date
2009-08-08